Taisho Pharmaceutical Holdings

What's New

May 11, 2012		Financial Statements for Fiscal 2011 / Reference Data
May 11, 2012		Notice Concerning Introduction of Stock Options for a Stock-Linked Compensation Plan
Apr 27, 2012		Notice Concerning the Conversion of TOKUHON Corporation into a Wholly Owned Subsidiary of Taisho Pharmaceutical Co., Ltd., a Wholly Owned Subsidiary of Taisho Pharmaceutical Holdings Co., Ltd., through Share Exchange
Mar 30, 2012		Integration of OTC Drug Business and Strengthening of Operating Base in Thai Market
Mar 12, 2012		Status of Stock Buyback on Open Market, End of Buyback Program
Mar 1, 2012		Status of Stock Buyback on Open Market

Dec 14, 2011		Bisphosphonate Antiresorptive Agent, Ibandronate Sodium Hydrate Injection, Demonstrates Efficacy in Osteoporosis in Phase II/III Trial
Sep 28, 2011		Notice of Dissolution of Subsidiary
Sep 8, 2011		Annual Report 2011
Sep 8, 2011		Investors' Guide 2011